Atossa Therapeutics (ATOS) Liabilities from Discontinued Operations (2014)
Atossa Therapeutics (ATOS) posted quarterly Liabilities from Discontinued Operations of 494252.0 for Q4 2014.
Atossa Therapeutics (ATOS) Liabilities from Discontinued Operations (2014) Analysis & Trends
Atossa Therapeutics (ATOS) has reported Liabilities from Discontinued Operations for 1 consecutive years, with 494252.0 the latest figure, recorded in Q4 2014.
- In Q4 2014, Liabilities from Discontinued Operations changed N/A year-over-year to 494252.0; the TTM figure through Dec 2014 stood at 494252.0 (changed N/A YoY), while the FY2014 annual figure was 494252.0, changed N/A from the prior year.
- Liabilities from Discontinued Operations steadied at 494252.0 in Q4 2014 per ATOS's latest filing.
- Across five years, Liabilities from Discontinued Operations topped out at 494252.0 in Q4 2014 and bottomed at 494252.0 in Q4 2014.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Atossa Therapeutics | 22.63 Mn | 22.63 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2014 | 494,252.00 |
| Dec 31, 2014 | 494,252.00 |